Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cyclacel Pharmaceuticals

5.00
+0.0000
Volume:103.00
Turnover:502.16
Market Cap:59.99M
PE:-2.39
High:5.00
Open:5.00
Low:5.00
Close:5.00
Loading ...
Nov 13, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 13, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Oct 31, 2019

Major Issues Report

Current report, item 5.07
Sep 10, 2019

Major Issues Report

Current report, item 8.01
Aug 13, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 13, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 12, 2019

Major Issues Report

Current report, item 3.01
Jun 20, 2019

Correspondence

[Cover]Correspondence
Jun 03, 2019

Major Issues Report

Current report, items 5.07 and 8.01
May 31, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 31, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 31, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 31, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 31, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 31, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 31, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 14, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 14, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 22, 2017

Beneficial Ownership Change

Jul 17, 2017

[Amend]Public Prospectus

Cyclacel制药有限公司